文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

肛门HPV型别从感染到癌症:按性别和HIV状态系统综述与荟萃分析

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis.
PubMed 文献 · Lancet Infect Dis · 2017-11-17

HPV16是肛门最具致癌性的型别,从高级别病变到癌仍有富集,但HIV阳性者肛门癌中HPV16占比低于HIV阴性者。

要点

  • HPV16是肛门最主要的致癌型别,从高级别病变到肛门癌仍富集。
  • HIV阳性者各诊断阶段HPV感染率均高于HIV阴性者。
  • HIV阳性肛门癌中HPV16占比低于HIV阴性者,归因分数更小。

核心结论

  • HPV16是肛门最具致癌性的HPV型别,在HIV阴性和阳性个体中从高级别病变到肛门癌均富集。
  • HIV阳性人群肛门癌归因于HPV16的比例小于HIV阴性人群。

研究设计与样本

  • 系统综述与荟萃分析,检索1986年1月至2017年7月MEDLINE、Embase和Cochrane Library,无语言限制。

主要发现

  • 正常细胞学中HPV患病率从HIV阴性女性的42%到HIV阳性男性的76%,各诊断阶段HIV阳性者均高于HIV阴性者。
  • HPV16阳性率从高级别病变到肛门癌仍增加,其他高危HPV型别在低级别或高级别病变中占比较高但肛门癌中患病率下降。
  • HIV阳性肛门癌中非HPV16成分的型别归因受多重HPV感染高患病率影响。

临床怎么用

  • 肛门癌预防可通过疫苗和筛查针对HPV16,尤其关注HIV阳性人群。
  • HIV阳性者肛门癌中HPV16占比较低,解读型别归因时需考虑多重感染。

局限性

  • HIV阳性肛门癌中非HPV16成分的型别归因受多重HPV感染高患病率影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on carcinogenicity of human papillomavirus (HPV) types in the anus are needed to inform anal cancer prevention through vaccination and screening. This is particularly the case for people infected with HIV, who are at an increased risk of anal cancer. METHODS: We did a systematic review of studies published from January, 1986, to July, 2017, in MEDLINE, Embase, and the Cochrane Library on anal HPV infection, without any language restrictions. Eligible studies reported type-specific HPV prevalence by strata of cytopathological or histopathological anal diagnosis, sex, and HIV status. Data requests were made to authors when necessary. We did a meta-analysis of type-specific HPV prevalence across the full spectrum of anal diagnoses, from normal cytology to anal cancer. We assessed the main outcome of type-specific HPV prevalence ratios [PR], calculated across strata of anal diagnoses, gender, or HIV status, by use of generalised linear models. FINDINGS: 95 studies were identified from the search, published between 1992-2017, from which 18 646 individuals fulfilled the criteria for inclusion in the analyses: 8534 people with normal cytology, 5730 with low-grade lesions, 2024 with high-grade lesions, and 2358 with anal cancer. HPV prevalence varied in normal cytology from 42% in HIV-negative women to 76% in HIV-positive men and, for each diagnosis, was higher in individuals who were HIV positive than those who were HIV negative. HPV16 positivity increased with diagnosis severity, being the only HPV type accounting for more HPV infection in anal cancer than normal cytology, both in individuals who were HIV negative (PR 5·0, 95% CI 3·8-6·6, p<0·0001) and those who were HIV positive (2·3, 1·9-2·7, p<0·0001). HPV16 positivity increased even between high-grade lesions and anal cancer, whereas other high-risk HPV types accounted for high proportions of low-grade or high-grade lesions but their prevalence decreased in anal cancer. However, HPV16 was less frequent in HIV-positive than HIV-negative anal cancer, both in men (PR 0·8, 95% CI 0·7-0·9, p<0·0001) and women (0·8, 0·6-1·0, p=0·063), and in HIV-positive versus HIV-negative high-grade lesions in women (0·6, 0·5-0·9, p=0·0077). Type-specific attribution of the non-HPV16 fraction of HIV-positive anal cancer is hindered by a high prevalence of multiple HPV infections. INTERPRETATION: HPV16 is by far the most carcinogenic HPV type in the anus, with enrichment of HPV16 even from high-grade lesions to anal cancer, both in individuals who are HIV negative and those who are HIV positive. Nevertheless, the fraction of anal cancer attributable to HPV16 is smaller in the HIV-positive population. FUNDING: International Agency for Research on Cancer.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lin C, Franceschi S, Clifford GM, et al. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis. 2017. PMID: 29158102. doi:10.1016/S1473-3099(17)30653-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。